Delphine BouillyThe Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM) is happy to announce that Delphine Bouilly is joining its team as Principal Investigator, Design and Application of Electronic Nanobiosensors research unit. She will also serve as assistant professor in the Physics Department of the Faculty of Arts and Science at the Université de Montréal.

Delphine Bouilly earned a Ph.D. in Physics from the Université de Montréal in 2013 before completing a postdoctoral fellowship at Columbia University, in New York City.

Bouilly earned many awards and scholarships over the course of her studies, including the prestigious Banting Postdoctoral Fellowship, awarded to the most qualified postdoctoral fellows with a highly promising research potential.

At IRIC, Delphine Bouilly and her team assemble ultra-miniature electronic circuits and sensors to explore the dynamics of the interactions between biological molecules (DNA and proteins) or the fluctuations within a single molecule. The goal is to develop new tools to identify biomarkers associated with various types of cancer and to improve our understanding of the mechanics of basic macromolecules. The results of this work will support the development of new therapies. Delphine Bouilly’s research program is complementary to the expertise of IRIC’s researchers and provides the Institute with many opportunities of collaboration.

“We are extremely happy to welcome Delphine at IRIC,” said Michel Bouvier, Chief Executive Officer at IRIC. “The Institute continues to expand and to recruit highly skilled researchers who complement the current team, thus accelerating the generation of new knowledge and the discovery of new anticancer therapies. On behalf of everyone at IRIC, I extend the warmest welcome to her.”

“The addition of Delphine to our team is excellent news,” added Marc Therrien, Scientific Director of IRIC. “Her research methods, her innovative ideas and her spirit of collaboration make her a perfect fit for the culture and processes of IRIC. It is through daring and complementary partnerships that we will ensure our continued success.”

Her official start date was on January 5, 2017.

About the Institute for Research in Immunology and Cancer

An ultra-modern research hub and training centre located in the heart of the Université de Montreal, the Institute for Research in Immunology and Cancer (IRIC) was created in 2003 to shed light on the mechanisms of cancer and discover new, more effective therapies to counter this disease. IRIC operates according to a model that is unique in Canada. Its innovative approach to research has already led to discoveries that will, over the coming years, have a significant impact on the fight against cancer. For further information.

 

Information

Olivier Dilain
Communication and media relations advisor
Institute for Research in Immunology and Cancer│IRIC
Université de Montréal
olivier.dilain@umontreal.ca│514-343-7283